The phase three clinical trial reached a milestone with its first American participant receiving treatment, advancing ...

Discover inspiring stories of global progress in primary education, health advancements, conservation efforts and more.

Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") today announces that the first patient in the United States (U.S.) has been dosed ...

A groundbreaking prostate treatment offering life-changing relief for men has reached Far North Queensland, transforming ...

A man from Brighton has spoken out after the NHS agreed to offer a life-extending drug to more men with prostate cancer. Currently only those with prostate cancer that has spread can get abiraterone ...

Life-extending prostate cancer drug to be made available to thousands more patients - Men with high-risk prostate cancer that ...

NHS England has announced that men whose high-risk prostate cancer has not yet spread will be able to receive the drug, ...

MELBOURNE, Australia and INDIANAPOLIS, Jan. 16, 2026 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, ...

The NHS has expanded access to a prostate cancer drug across England in a move which could stop 8,000 former cancer patients from being told their illness has returned.

THOUSANDS more men will get a life-saving prostate cancer drug on the NHS in a win for The Sun after we revealed the deadly ...

The patients received Lutetium (177Lu) rhPSMA-10.1 Injections at both St Bartholomew's Hospital, London, and The James Cook University Hospital, Middlesbrough -- Lutetium (177Lu) rhPSMA-10.1 Injection ...